Correlation Between Bolt Biotherapeutics and Coherus BioSciences

Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Coherus BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Coherus BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bolt Biotherapeutics and Coherus BioSciences, you can compare the effects of market volatilities on Bolt Biotherapeutics and Coherus BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Coherus BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Coherus BioSciences.

Diversification Opportunities for Bolt Biotherapeutics and Coherus BioSciences

0.91

Correlation Coefficient

Bolt Biotherapeutics  Coherus BioSciences

Almost no diversification

The 3 months correlation between Bolt and Coherus is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Coherus BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coherus BioSciences and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Coherus BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coherus BioSciences has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Coherus BioSciences go up and down completely randomly.

Pair Corralation between Bolt Biotherapeutics and Coherus BioSciences

Given the investment horizon of 90 days Bolt Biotherapeutics is expected to generate 0.63 times more return on investment than Coherus BioSciences. However, Bolt Biotherapeutics is 1.59 times less risky than Coherus BioSciences. It trades about -0.13 of its potential returns per unit of risk. Coherus BioSciences is currently generating about -0.15 per unit of risk. If you would invest  57.00  in Bolt Biotherapeutics on December 28, 2024 and sell it today you would lose (14.50) from holding Bolt Biotherapeutics or give up 25.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Bolt Biotherapeutics  vs.  Coherus BioSciences

Bolt Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bolt Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Coherus BioSciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Coherus BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Bolt Biotherapeutics and Coherus BioSciences

The main advantage of trading using opposite Bolt Biotherapeutics and Coherus BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Coherus BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will offset losses from the drop in Coherus BioSciences' long position.

The idea behind Bolt Biotherapeutics and Coherus BioSciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.